Search Results - "Divanon, F"

Methodology to develop a virtual reality training for good practices in the preparation of anti-cancer drugs by Descotes, G, Moine, M, Beau, F, Noyer, V, Nicoulaud, J-C, Divanon, F, Jourdan, N, Bobay-Madic, A, Rodier, S

“…Describe the process for designing and creating SimUPAC 360°, a virtual reality training in anti-cancer drug production units. A multi-centre (a University…”
Get more information

Experience with use of recombinant activated factor VII by Divanon, F., Hecquard, C., Borel-Derlon, A.

“…Recombinant activated factor VII (rFVIIa) has recently been introduced for improving haemostasis in haemophiliac patients developing alloantibodies…”
Get full text

284P Interest of a multidisciplinary approach in the initiation of oral therapies in metastatic breast cancer (MBC): Experience of a French comprehensive cancer center by Dupont, C., Morel, A., Martel, B., Duval, C., Divanon, F., Levy, C.

Get full text

Comparative evaluation of quality of life in patients with schizophrenia treated with conventional versus atypical neuroleptics: results of a transversal study by Divanon, F, Delamillieure, P, Lehaguez, A, Vasse, T, Morello, R, Gourevitch, R, Langlois, S, Assouly-Besse, F, Guelfi, J D, Petit, M, Dollfus, S

“…The World Health Organization has defined quality of life as "the perception of an individual, his/her place in life, in the context of the culture and the…”
Get more information

Benzodiazepines: Toxic Serum Concentrations in Positive Enzyme Immunoassay Responses by Divanon, F., Debruyne, D., Moulin, M., Leroyer, R.

“…A total of 588 blood specimens collected in an emergency unit were screened for benzodiazepines (BZDs) using enzyme-multiplied immunoassay and gas…”
Get full text

5PSQ-194 Management of experimental health products in hospital pharmacies: a national survey by Delavoipière, E, Bouglé, C, Daouphars, M, Donnadieu, N, Bernard, L, Morello, R, Montreuil, J, Divanon, F, Alix, A

“…Background and importanceThe management of investigational health products (IHPs) is a major part of conducting clinical trials (CTs). It presents specific…”
Get full text

Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff by Benoist, Hubert, Busson, Amandine, Faveyrial, Audrey, Bouhier-Leporrier, Karine, Divanon, Fabienne, Breuil, Cécile, Roger-Leenaert, Sophie, Palix, Agnès, Odou, Pascal, Simon, Nicolas, Saint-Lorant, Guillaume

“…Antineoplastic drug exposure is a major problem in regard to caregivers' health. The aim of the present study was to assess the perception, knowledge, and…”
Get full text

5PSQ-227 Clinical trials: a standardised self-assessment tool to reduce the multiple risks of the pharmaceutical circuit by Delavoipière, E, Bouglé, C, Bernard, L, Chevrier, R, Lortal, B, Peyron, F, Renon-Carron, F, Thielemans, B, Thole, A, Divanon, F, Alix, A

“…Background and importanceDespite a strict regulatory framework of clinical trials (CTs), few standardised tools are available. Our national survey conducted in…”
Get full text

FICHE-YOUNG: FIrst-line treatment CHoicE in hormone receptor positive (HR+)/HER2- negative metastatic breast cancer patients (MBC) ≤45 years old. A large observational multicenter cohort survival analysis by Pistilli, B., Lardy-Cleaud, A., Jacquet, E., Delaloge, S., Cottu, P., Debled, M., Vanlemmens, L., Leheurteur, M., Divanon, F., Gonçalves, A., Laurent, C., Coudert, B., Chamorey, E., Campion, L., Mouret-Reynier, M-A., Breton, M., Petit, T., Simon, G., Cailliot, C., Bachelot, T.

Get full text

Intérêt de l'interleukine-2 en association au traitement antirétroviral chez des patients VIH by DIVANON, F, PARIENTI, J.-J, VERDON, R

Get full text

Effets indésirables des antiprotéases du VIH by DIVANON, F, LEROYER, R, CLOITRE, F, LE DOZE, F

Get full text

A propos d'une intoxication par l'éthylène glycol by DIVANON, F, LEROYER, R, LEPRINCE, M. C, RIBY, J. P, COLLET, C

Get full text

Innocuité des anticorps monoclonaux pour le manipulateur : mythe ou réalité ? A propos d'une enquête de pratiques professionnelles by PIGNERET-BERNARD, S, SAINT-LORANT, G, DIVANON, F

Get full text

Economic impact of rationalized antibiotic therapy in a general hospital by Divanon, F, Hazera, P, el Baroudi, N E, Rennes, C, Tanquerel, J J, Beck, P

“…To evaluate the economic impact and the bacterial resistance rates after 2 years of a rationalized antibiotic prescription program in a 502-bed hospital…”
Get full text

Anaphylactoid reactions to an injectable solution of a cremophor-containing solution of multivitamins by Mounier, P, Laroche, D, Divanon, F, Mosquet, B, Vergnaud, M C, Esse-Comlan, A, Piquet, M A, Bricard, H

“…We report four anaphylactoid reactions after intravenous administration of a cremophor-containing multivitamin hydrosol (Hydrosol Polyvitaminé Roche), observed…”
Get more information

Impact économique de la rationalisation de l’antibiothérapie dans un centre hospitalier général by Divanon, F, Hazera, P, El Baroudi, N.E, Rennes, C, Tanquerel, J.J, Beck, P

“…Propos. – Analyser l’impact économique et l’évolution de la résistance des bactéries après la mise en place d’un programme de rationalisation de l’utilisation…”
Get full text

Severe ischemic colitis after administration of Rhinadvil in a fifteen year old girl by Fatome, Armelle, Ollivier, Isabelle, Even, Christian, Divanon, Fabienne, Saulnier, Hugues, Dao, Thong

Get full text

L'Addition De Polyvitamines A Une Perfusion n'Est Pas Un Geste Anodin by Mounier, P., Laroche, D., Divanon, F., Mosquet, B., Vergnaud, M.C., Esse-Comlan, A., Piquet, M.A., Bricard, H.

Get full text